Top-Rated StocksTop-RatedNASDAQ:PRVA Privia Health Group (PRVA) Stock Price, News & Analysis $20.46 +0.47 (+2.35%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$19.99▼$20.5050-Day Range$16.09▼$20.4652-Week Range$15.92▼$28.10Volume423,609 shsAverage Volume693,804 shsMarket Capitalization$2.44 billionP/E Ratio136.40Dividend YieldN/APrice Target$24.54 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Privia Health Group alerts: Email Address Privia Health Group MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.93 Rating ScoreUpside/Downside19.9% Upside$24.54 Price TargetShort InterestBearish5.98% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.36Based on 3 Articles This WeekInsider TradingAcquiring Shares$4.75 M Bought Last QuarterProj. Earnings Growth45.00%From $0.20 to $0.29 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.31 out of 5 starsMedical Sector177th out of 936 stocksHealth Services Industry1st out of 11 stocks 3.5 Analyst's Opinion Consensus RatingPrivia Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.93, and is based on 11 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoveragePrivia Health Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Privia Health Group's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted5.98% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 7.2.Change versus previous monthShort interest in Privia Health Group has recently decreased by 4.96%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRVA. Previous Next 3.5 News and Social Media Coverage News SentimentPrivia Health Group has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Privia Health Group this week, compared to 3 articles on an average week.Search Interest3 people have searched for PRVA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows3 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have bought 473.26% more of their company's stock than they have sold. Specifically, they have bought $4,745,481.00 in company stock and sold $827,810.00 in company stock.Percentage Held by Insiders14.20% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Privia Health Group's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Privia Health Group are expected to grow by 45.00% in the coming year, from $0.20 to $0.29 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 136.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.19.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 136.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 152.08.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 3.08. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 3.98. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Privia Health Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About Privia Health Group Stock (NASDAQ:PRVA)Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Read More PRVA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PRVA Stock News HeadlinesJuly 20, 2024 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives $24.54 Consensus Target Price from BrokeragesMay 30, 2024 | globenewswire.comPrivia Health to Participate in the William Blair Growth Stock ConferenceJuly 27, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! May 26, 2024 | 247wallst.comInsider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout CandidateMay 23, 2024 | finance.yahoo.comDirector Thomas McCarthy Acquires 10,000 Shares of Privia Health Group Inc (PRVA)May 21, 2024 | seekingalpha.comPrivia Health: Key Lessons Learned (Rating Downgrade)May 20, 2024 | markets.businessinsider.comPrivia Health Group (PRVA) Gets a Hold from BarclaysMay 15, 2024 | markets.businessinsider.comWhat 12 Analyst Ratings Have To Say About Privia Health GrJuly 27, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! May 14, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)May 13, 2024 | finance.yahoo.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comPrivia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational GrowthMay 10, 2024 | finance.yahoo.comPrivia Health Group First Quarter 2024 Earnings: EPS: US$0.025 (vs US$0.064 in 1Q 2023)May 9, 2024 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Reports First Quarter 2024 Financial ResultsMay 9, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth OutlookMay 9, 2024 | markets.businessinsider.comPrivia Health Q1 Net Profit More Than Halves; Backs FY24 Revenue OutlookMay 9, 2024 | msn.comPrivia Health Group Non-GAAP EPS of $0.18 beats by $0.03, revenue of $415.2M beats by $20.45MMay 9, 2024 | seekingalpha.comPrivia Health Group, Inc. 2024 Q1 - Results - Earnings Call PresentationSee More Headlines Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/27/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:PRVA CUSIPN/A CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees810Year FoundedN/APrice Target and Rating Average Stock Price Target$24.54 High Stock Price Target$30.00 Low Stock Price Target$19.00 Potential Upside/Downside+19.9%Consensus RatingModerate Buy Rating Score (0-4)2.93 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)$0.15 Trailing P/E Ratio136.40 Forward P/E Ratio102.30 P/E Growth3.08Net Income$23.08 million Net Margins1.11% Pretax Margin1.44% Return on Equity3.13% Return on Assets1.89% Debt Debt-to-Equity RatioN/A Current Ratio1.80 Quick Ratio1.80 Sales & Book Value Annual Sales$1.69 billion Price / Sales1.45 Cash Flow$0.26 per share Price / Cash Flow78.35 Book Value$5.14 per share Price / Book3.98Miscellaneous Outstanding Shares119,318,000Free Float102,375,000Market Cap$2.44 billion OptionableOptionable Beta0.78 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Parth Mehrotra (Age 45)CEO & Director Comp: $1.19MMr. David Mountcastle CPA (Age 54)MBA, Executive VP, CFO & Principal Accounting Officer Comp: $713.72kMr. Thomas Bartrum (Age 56)Executive Officer Comp: $533.02kMr. Sarath DegalaChief Operating OfficerMr. Chris VoigtExecutive VP & Chief Technology OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate CommunicationsMs. Dana Fields CPAChief Audit & Compliance OfficerMr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate SecretaryMs. Jenny HardingChief People OfficerMr. Jay StevensSenior VP & Chief Growth OfficerMore ExecutivesKey CompetitorsApollo MedicalNASDAQ:AMEHMagellan HealthNASDAQ:MGLNLifeStance Health GroupNASDAQ:LFSTagilon healthNYSE:AGLAlignment HealthcareNASDAQ:ALHCView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 594,571 shares on 7/26/2024Ownership: 2.414%Allspring Global Investments Holdings LLCBought 788 shares on 7/26/2024Ownership: 0.008%Louisiana State Employees Retirement SystemBought 1,300 shares on 7/24/2024Ownership: 0.044%Nisa Investment Advisors LLCBought 930 shares on 7/20/2024Ownership: 0.002%Sequoia Financial Advisors LLCSold 1,716 shares on 7/16/2024Ownership: 0.022%View All Insider TransactionsView All Institutional Transactions PRVA Stock Analysis - Frequently Asked Questions How have PRVA shares performed this year? Privia Health Group's stock was trading at $23.03 at the start of the year. Since then, PRVA shares have decreased by 11.2% and is now trading at $20.46. View the best growth stocks for 2024 here. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings results on Thursday, May, 9th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.05 by $0.03. The company had revenue of $415.24 million for the quarter, compared to analyst estimates of $435.07 million. Privia Health Group had a net margin of 1.11% and a trailing twelve-month return on equity of 3.13%. When did Privia Health Group IPO? Privia Health Group (PRVA) raised $351 million in an IPO on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are Privia Health Group's major shareholders? Top institutional investors of Privia Health Group include Bank of New York Mellon Corp (2.41%), Louisiana State Employees Retirement System (0.04%), Harbor Capital Advisors Inc. (0.03%) and Sequoia Financial Advisors LLC (0.02%). Insiders that own company stock include Adam Boehler, William M Sullivan, Jeffrey B Butler, David Mountcastle, Parth Mehrotra, Advisors LLC Mbd, Thomas Bartrum, Matthew Shawn Morris, Pamplona Capital Partners Iii, and Jeffrey Daniel Bernstein. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:PRVA) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
